Skip to main content
. 2021 Dec 22;8(1):e000529. doi: 10.1136/lupus-2021-000529

Figure 3.

Figure 3

Frequency (%) of use of outcome measures in CLE RCTs (n=33). CLASI, Cutaneous Lupus Erythematous Disease Area and Severity Index; CLE, cutaneous lupus erythematosus; DLQI, Dermatology Life Quality Index; NRS, Numeric Rating Scale; RCT, randomised controlled trial; SF-36, Short Form Health Survey; VAS, Visual Analogue Scale.